Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.15
Bid: 8.00
Ask: 8.30
Change: -0.15 (-1.81%)
Spread: 0.30 (3.75%)
Open: 8.30
High: 8.45
Low: 8.15
Yest. Close: 8.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

4 Aug 20 19:16

Physiomics wins contract with Japan-based Astellas Pharma

(Sharecast News) - Oncology consultancy Physiomics announced on Friday that it has been awarded a contract by a new client, Japan-based global pharmaceutical company Astellas Pharma.

31 Jul 20 12:08

IN BRIEF: Physiomics Has No Explanation For Share Price Surge

IN BRIEF: Physiomics Has No Explanation For Share Price Surge

22 Jul 20 20:43

Physiomics Raises New Funds To "Further Develop Its Business"

Physiomics Raises New Funds To "Further Develop Its Business"

27 May 20 17:13

Physiomics raises £829,000 to fund further development

(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.

27 May 20 10:30

Physiomics Secures Additional Contract With Bicycle Therapeutics

Physiomics Secures Additional Contract With Bicycle Therapeutics

6 Apr 20 17:20

Physiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak

Physiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak

19 Mar 20 12:44

Physiomics receives 'Connect' funding award from NIHR

(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Invention for Innovation' (i4i) programme, for the continued development of its tool for use in the personalised treatment of cancer.

10 Mar 20 11:39

Physiomics Secures Contract Extension With Existing Client Merck

Physiomics Secures Contract Extension With Existing Client Merck

5 Mar 20 13:57

Physiomics First Half Revenue Rises But No Grants Means Widened Loss

Physiomics First Half Revenue Rises But No Grants Means Widened Loss

3 Mar 20 11:11

Physiomics H1 revenues on the rise

(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.

3 Mar 20 10:19

Physiomics Signs Further Project Agreement With CellCentric

Physiomics Signs Further Project Agreement With CellCentric

23 Dec 19 10:43

Physiomics scores further project agreement with CellCentric

(Sharecast News) - Oncology consultancy business Physiomics has been awarded a further project agreement with British biotech outfit CellCentric.

23 Dec 19 08:33

Merck Commits To Initial Contracts With Physiomics For 2020

Merck Commits To Initial Contracts With Physiomics For 2020

20 Dec 19 15:26

Physiomics surges amid deepened Merck collaboration

(Sharecast News) - Shares of Physiomics leapt on Friday after it signed up to a £250,000 tranche of projects with pharmaceutical giant Merck and said trading was in line with expectations.

20 Dec 19 11:27

Login to your account

Don't have an account? Click here to register.